Yi Chang Ren Fu Pharma Co., Ltd. romanized
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference 4b825ed2aa
Drug names119First applicant · distinct drug namesAcceptance records294First applicant · distinct acceptance numbersUnder-review numbers44First applicant · current under-review listCo-applicant records6Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/13 06:42.
Drug filings
294 acceptance records as first applicant, grouped into 119 source drug names. Source data as of 2026/11/13 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Buprenorphine Hydrochloride and Naloxone Hydrochloride Sublingual Tablets 2 records · Latest accepted 2026/11/12
Generic · 2
舒芬太尼透皮贴剂 · No verified English name 2 records · Latest accepted 2026/11/10
Supplement · 2
Brivaracetam Tablets 5 records · Latest accepted 2026/11/09
Generic · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602745 | Generic | 2026/11/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2602744 | Generic | 2026/11/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2602743 | Generic | 2026/11/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2400065 | Generic | 2024/03/26 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2400064 | Generic | 2024/03/26 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Granisetron Transdermal Patches 1 records · Latest accepted 2026/10/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602612 | Generic | 2026/10/23 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
HW231019片 · No verified English name 4 records · Latest accepted 2026/09/08
Supplement · 2New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2600367 | Supplement | 2026/09/08 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHB2600060 | Supplement | 2026/02/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2401448 | New drug | 2024/12/26 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2401447 | New drug | 2024/12/26 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Midazolam Nasal Spray 1 records · Latest accepted 2026/08/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2600092 | Generic | 2026/08/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Pregabalin Extended release Tablets 10 records · Latest accepted 2026/08/27
Generic · 10
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602149 | Generic | 2026/08/27 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2602148 | Generic | 2026/08/27 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2602147 | Generic | 2026/08/27 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2602018 | Generic | 2026/08/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2602017 | Generic | 2026/08/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2602016 | Generic | 2026/08/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2500138 | Generic | 2025/08/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2500137 | Generic | 2025/08/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2200112 | Generic | 2022/12/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2200111 | Generic | 2022/12/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Remimazolam Besylate For Injection 15 records · Latest accepted 2026/08/17
Supplement · 10New drug · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601562 | Supplement | 2026/08/17 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601561 | Supplement | 2026/08/17 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2402029 | Supplement | 2024/11/30 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2402028 | Supplement | 2024/11/30 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHS2400093 | New drug | 2024/09/15 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHS2400092 | New drug | 2024/09/15 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2401293 | Supplement | 2024/08/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2401292 | Supplement | 2024/08/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2300276 | Supplement | 2023/02/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2300275 | Supplement | 2023/02/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2201412 | Supplement | 2022/08/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2102435 | Supplement | 2021/12/24 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHS2101053 | New drug | 2021/11/17 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2101294 | New drug | 2021/07/15 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHS2101026 | New drug | 2021/07/01 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Clobazam Tablets 4 records · Latest accepted 2026/08/14
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601549 | Supplement | 2026/08/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601548 | Supplement | 2026/08/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200436 | Generic | 2022/03/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200435 | Generic | 2022/03/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Mirogabalin Besilate Tablets 1 records · Latest accepted 2026/08/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601981 | Generic | 2026/08/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Nalbuphine Hydrochloride Injection 14 records · Latest accepted 2026/07/29
Supplement · 8New drug · 4Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601458 | Supplement | 2026/07/29 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601457 | Supplement | 2026/07/29 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601456 | Supplement | 2026/07/29 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601165 | Supplement | 2026/06/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601164 | Supplement | 2026/06/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601162 | Supplement | 2026/06/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHS2600013 | New drug | 2026/01/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHS2600012 | New drug | 2026/01/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHS2600011 | New drug | 2026/01/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2202328 | Supplement | 2022/12/29 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2202118 | Generic | 2022/12/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2202117 | Generic | 2022/12/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2200505 | New drug | 2022/07/18 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2200559 | Supplement | 2022/03/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Buprenorphine Transdermal Patches 2 records · Latest accepted 2026/07/16
Generic · 2
琥珀酸地文拉法辛缓释片 · No verified English name 3 records · Latest accepted 2026/07/02
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601248 | Supplement | 2026/07/02 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601247 | Supplement | 2026/07/02 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601246 | Supplement | 2026/07/02 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
盐酸艾司氯胺酮鼻喷雾剂 · No verified English name 1 records · Latest accepted 2026/06/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2600074 | Generic | 2026/06/24 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Tapentadol Hydrochloride Extended Release Tablets 3 records · Latest accepted 2026/06/10
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601090 | Supplement | 2026/06/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601089 | Supplement | 2026/06/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601088 | Supplement | 2026/06/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Landiolol Hydrochloride for Injection 1 records · Latest accepted 2026/06/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601236 | Generic | 2026/06/01 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Sufentanil Citrate Injection 15 records · Latest accepted 2026/05/28
Generic · 5Supplement · 5New drug · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2600068 | Generic | 2026/05/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2600067 | Generic | 2026/05/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2600066 | Generic | 2026/05/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2600065 | Generic | 2026/05/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2600064 | Generic | 2026/05/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2501065 | Supplement | 2025/05/27 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2500881 | Supplement | 2025/04/29 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2500880 | Supplement | 2025/04/29 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2400470 | New drug | 2024/05/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2400469 | New drug | 2024/05/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2400468 | New drug | 2024/05/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2400467 | New drug | 2024/05/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2400466 | New drug | 2024/05/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2201500 | Supplement | 2022/08/23 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2140007 | Supplement | 2021/01/27 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
盐酸氢吗啡酮片 · No verified English name 2 records · Latest accepted 2026/04/21
Generic · 2
盐酸艾司氯胺酮口颊粘膜溶液 · No verified English name 1 records · Latest accepted 2026/04/16
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600442 | New drug | 2026/04/16 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Dexmethylphenidate Hydrochloride Exended-release Capsules 4 records · Latest accepted 2026/04/08
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600792 | Generic | 2026/04/08 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2600791 | Generic | 2026/04/08 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2600482 | Generic | 2026/02/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2600481 | Generic | 2026/02/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
盐酸他喷他多口服溶液 · No verified English name 1 records · Latest accepted 2026/04/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2600038 | Generic | 2026/04/07 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Enzalutamide Soft Capsules 2 records · Latest accepted 2026/03/25
Supplement · 1Generic · 1
氨酚羟考酮缓释片 · No verified English name 3 records · Latest accepted 2026/03/12
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600041 | New drug | 2026/03/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2101702 | New drug | 2021/12/08 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2101701 | New drug | 2021/12/08 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
马立巴韦片 · No verified English name 1 records · Latest accepted 2026/03/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600631 | Generic | 2026/03/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Vonoprazan Fumarate Tablets 4 records · Latest accepted 2026/03/04
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600439 | Supplement | 2026/03/04 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2600438 | Supplement | 2026/03/04 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200735 | Generic | 2022/05/18 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200734 | Generic | 2022/05/18 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
盐酸R-氯胺酮注射液 · No verified English name 1 records · Latest accepted 2026/03/04
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600267 | New drug | 2026/03/04 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
RFUS-188注射液 · No verified English name 1 records · Latest accepted 2026/02/13
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600189 | New drug | 2026/02/13 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Carbamazepine Tablets 1 records · Latest accepted 2026/02/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600291 | Supplement | 2026/02/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
RFUS-1646片 · No verified English name 4 records · Latest accepted 2026/01/22
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600101 | New drug | 2026/01/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2600100 | New drug | 2026/01/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2600097 | New drug | 2026/01/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2600096 | New drug | 2026/01/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Palonosetron Hydrochloride Soft Capsules 1 records · Latest accepted 2026/01/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600084 | Generic | 2026/01/07 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Ren Fu Pu Ke Pharma (Wuhan) Co., Ltd. romanized | CDE ↗ |
Loxoprofen Sodium Patches 2 records · Latest accepted 2025/12/17
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504298 | Generic | 2025/12/17 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Hunan Pai Ge Lan Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2504297 | Generic | 2025/12/17 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Hunan Pai Ge Lan Pharma Co., Ltd. romanized | CDE ↗ |
Lisdexamfetamine Dimesylate capsules 4 records · Latest accepted 2025/11/19
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504006 | Generic | 2025/11/19 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2504004 | Generic | 2025/11/19 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2504003 | Generic | 2025/11/19 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2504001 | Generic | 2025/11/19 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
奥氮平萨米多芬片 · No verified English name 3 records · Latest accepted 2025/11/12
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2500202 | Generic | 2025/11/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2500201 | Generic | 2025/11/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2500200 | Generic | 2025/11/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Gadoxetic Acid Disodium Injection 1 records · Latest accepted 2025/11/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503940 | Generic | 2025/11/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Pemafibrate Tablets 1 records · Latest accepted 2025/10/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503652 | Generic | 2025/10/13 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Letermovir Tablets 1 records · Latest accepted 2025/09/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503589 | Generic | 2025/09/30 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Gadobutrol Injection 2 records · Latest accepted 2025/09/09
Generic · 2
Alfentanil Hydrochloride Injection 4 records · Latest accepted 2025/08/20
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501650 | Supplement | 2025/08/20 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2201107 | Supplement | 2022/07/06 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2201106 | Supplement | 2022/07/06 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2201105 | Supplement | 2022/07/06 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Valganciclovir Hydrochloride Tablets 1 records · Latest accepted 2025/07/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502702 | Generic | 2025/07/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | CDE ↗ |
Guanfacine Hydrochloride Extended Release Tablets 8 records · Latest accepted 2025/07/11
Generic · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502473 | Generic | 2025/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2502472 | Generic | 2025/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2502471 | Generic | 2025/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2502470 | Generic | 2025/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2101055 | Generic | 2021/12/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2101054 | Generic | 2021/12/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2101053 | Generic | 2021/12/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2101052 | Generic | 2021/12/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
氢可酮布洛芬片 · No verified English name 2 records · Latest accepted 2025/07/04
Supplement · 2
注射用RF16001 · No verified English name 4 records · Latest accepted 2025/07/04
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2500175 | Supplement | 2025/07/04 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Hui Li Pharma (Suzhou) Co., Ltd. romanized | CDE ↗ |
| CXHB2500174 | Supplement | 2025/07/04 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Hui Li Pharma (Suzhou) Co., Ltd. romanized | CDE ↗ |
| CXHB2500068 | Supplement | 2025/03/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Hui Li Pharma (Suzhou) Co., Ltd. romanized | CDE ↗ |
| CXHB2500067 | Supplement | 2025/03/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Hui Li Pharma (Suzhou) Co., Ltd. romanized | CDE ↗ |
对乙酰氨基酚甘露醇注射液 · No verified English name 1 records · Latest accepted 2025/06/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501283 | Supplement | 2025/06/30 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Guangzhou Lv Shi Zi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
维生素B12注射液 · No verified English name 1 records · Latest accepted 2025/05/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550190 | Supplement | 2025/05/15 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
维生素B6注射液 · No verified English name 1 records · Latest accepted 2025/04/08
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550166 | Supplement | 2025/04/08 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Brexpiprazole Tablets 6 records · Latest accepted 2025/04/07
Generic · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501306 | Generic | 2025/04/07 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2501305 | Generic | 2025/04/07 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2501304 | Generic | 2025/04/07 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2400226 | Generic | 2024/11/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2400225 | Generic | 2024/11/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2400224 | Generic | 2024/11/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Esketamine Hydrochloride Injection 3 records · Latest accepted 2025/03/21
Supplement · 1New drug · 1Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500579 | Supplement | 2025/03/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2401398 | New drug | 2024/12/19 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2202125 | Generic | 2022/12/29 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
RFUS-949片 · No verified English name 2 records · Latest accepted 2025/03/18
New drug · 2
血管紧张素II注射液 · No verified English name 1 records · Latest accepted 2025/02/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2500036 | Generic | 2025/02/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Oseltamivir Phosphate For Oral Suspension 1 records · Latest accepted 2025/01/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500067 | Generic | 2025/01/06 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
咪达唑仑口服溶液 · No verified English name 1 records · Latest accepted 2024/12/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402229 | Supplement | 2024/12/27 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
甲苯磺酸卢美哌隆胶囊 · No verified English name 1 records · Latest accepted 2024/12/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2400269 | Generic | 2024/12/25 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
CXJM-66注射液 · No verified English name 1 records · Latest accepted 2024/12/14
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2401378 | New drug | 2024/12/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Oxycodone Hydrochloride Prolonged-release Tablets 4 records · Latest accepted 2024/12/14
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402141 | Supplement | 2024/12/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2300579 | Supplement | 2023/03/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2101713 | Generic | 2021/09/13 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2101217 | Generic | 2021/05/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
RFUS-301注射剂 · No verified English name 1 records · Latest accepted 2024/12/10
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2401333 | New drug | 2024/12/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
注射用磷丙泊酚二钠 · No verified English name 4 records · Latest accepted 2024/11/22
Supplement · 2New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401969 | Supplement | 2024/11/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2401968 | Supplement | 2024/11/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2400016 | New drug | 2024/01/05 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2400015 | New drug | 2024/01/05 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Carbamazepine Sustained-Release Tablets（II） 3 records · Latest accepted 2024/09/25
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403175 | Generic | 2024/09/25 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2403174 | Generic | 2024/09/25 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2403173 | Generic | 2024/09/25 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Fentanyl Citrate Buccal Tablets 7 records · Latest accepted 2024/09/25
Generic · 6Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403172 | Generic | 2024/09/25 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2403171 | Generic | 2024/09/25 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2403170 | Generic | 2024/09/25 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2403169 | Generic | 2024/09/25 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2403168 | Generic | 2024/09/25 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2403167 | Generic | 2024/09/25 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2102115 | Supplement | 2021/11/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Ibuprofen Tablets 5 records · Latest accepted 2024/09/13
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401447 | Supplement | 2024/09/13 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2201179 | Supplement | 2022/07/15 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2201178 | Supplement | 2022/07/15 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2200853 | Supplement | 2022/06/01 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2200852 | Supplement | 2022/06/01 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
司美格鲁肽注射液 · No verified English name 2 records · Latest accepted 2024/08/09
New drug · 2
Amikacin Sulfate injection 1 records · Latest accepted 2024/08/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450422 | Supplement | 2024/08/06 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Flumazenil Injection 1 records · Latest accepted 2024/07/31
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401155 | Supplement | 2024/07/31 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
注射用RFUS-250 · No verified English name 2 records · Latest accepted 2024/05/14
New drug · 2
Valacyclovir Hydrochloride Tablets 2 records · Latest accepted 2024/04/16
Supplement · 2
Hydromorphone Hydrochloride Injection 2 records · Latest accepted 2024/02/08
Supplement · 2
Oxycodone Hydrochloride Tablets 2 records · Latest accepted 2024/01/15
Generic · 2
Divalproex Sodium Extended-Release Tablets 2 records · Latest accepted 2024/01/05
Generic · 2
Flurbiprofen Axetil Injection 2 records · Latest accepted 2024/01/04
Generic · 2
Dimethyl Fumarate Delayed-release Capsules 1 records · Latest accepted 2023/12/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303483 | Generic | 2023/12/15 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Norepinephrine Bitartrate Injection 1 records · Latest accepted 2023/12/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303435 | Generic | 2023/12/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Piracetam Tablets 2 records · Latest accepted 2023/11/15
Supplement · 2
Lincomycin Injection 1 records · Latest accepted 2023/11/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350826 | Supplement | 2023/11/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Febuxostat Tablets 3 records · Latest accepted 2023/10/25
Supplement · 1Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302361 | Supplement | 2023/10/25 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2102240 | Generic | 2021/12/23 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2102239 | Generic | 2021/12/23 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Midazolam Maleate Tablets 1 records · Latest accepted 2023/10/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302782 | Generic | 2023/10/17 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Tapentadol Hydrochloride Tablets 3 records · Latest accepted 2023/09/22
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302569 | Generic | 2023/09/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2302568 | Generic | 2023/09/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2302567 | Generic | 2023/09/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Methylnaltrexone Bromide Tablets 1 records · Latest accepted 2023/09/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2300119 | Generic | 2023/09/19 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
依托咪酯中/长链脂肪乳注射液 · No verified English name 1 records · Latest accepted 2023/07/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301866 | Generic | 2023/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Celecoxib Capsules 1 records · Latest accepted 2023/07/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301851 | Generic | 2023/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Ursodeoxycholic Acid Capsules 1 records · Latest accepted 2023/07/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301832 | Generic | 2023/07/07 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Carbocisteine Oral Solution 1 records · Latest accepted 2023/07/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301793 | Generic | 2023/07/04 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Metoprolol Succinate Sustained-release Tablets 6 records · Latest accepted 2023/06/17
Supplement · 2Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301354 | Supplement | 2023/06/17 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2301353 | Supplement | 2023/06/17 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200346 | Generic | 2022/02/18 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200345 | Generic | 2022/02/18 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2101192 | Generic | 2021/05/26 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2101191 | Generic | 2021/05/26 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Desvenlafaxine Extended-release Tablets 4 records · Latest accepted 2023/05/31
Generic · 3Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301475 | Generic | 2023/05/31 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2301474 | Generic | 2023/05/31 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2301473 | Generic | 2023/05/31 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2101246 | Supplement | 2021/05/17 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Bupropion hydrochloride sustained-release tablets 5 records · Latest accepted 2023/05/30
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301220 | Supplement | 2023/05/30 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2300834 | Supplement | 2023/04/20 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2200537 | Supplement | 2022/03/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2200536 | Supplement | 2022/03/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2200535 | Supplement | 2022/03/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Oseltamivir Phosphate Capsules 1 records · Latest accepted 2023/04/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301116 | Generic | 2023/04/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | CDE ↗ |
Rivastigmine transdermal system 2 records · Latest accepted 2023/03/16
Generic · 2
Tolterodine Tartrate Extended Release Capsules 2 records · Latest accepted 2023/02/09
Generic · 2
维生素B1片 · No verified English name 1 records · Latest accepted 2023/02/08
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300230 | Supplement | 2023/02/08 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Fosaprepitant Dimeglumine for Injection 1 records · Latest accepted 2023/01/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300157 | Generic | 2023/01/17 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
维生素C片 · No verified English name 1 records · Latest accepted 2023/01/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300066 | Supplement | 2023/01/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Paracetamol and Tramadol Hydrochloride Tablets 1 records · Latest accepted 2023/01/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350024 | Supplement | 2023/01/06 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Remifentanil Hydrochloride for Injection 3 records · Latest accepted 2022/12/30
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2202147 | Generic | 2022/12/30 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2202146 | Generic | 2022/12/30 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2202145 | Generic | 2022/12/30 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Hydrocodone Bitartrate and Ibuprofen Tablets 2 records · Latest accepted 2022/11/11
Generic · 2
钠钾镁钙葡萄糖注射液 · No verified English name 2 records · Latest accepted 2022/11/11
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201956 | Generic | 2022/11/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Yi Chang San Xia Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2201707 | Generic | 2022/10/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Yi Chang San Xia Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Choline Fenofibrate Sustained-release Capsules 2 records · Latest accepted 2022/09/23
Generic · 2
Clobazam Oral Suspension 1 records · Latest accepted 2022/08/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2200064 | Generic | 2022/08/16 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Midazolam Injection 4 records · Latest accepted 2022/08/01
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201324 | Supplement | 2022/08/01 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2102032 | Supplement | 2021/10/26 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2102031 | Supplement | 2021/10/26 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2102030 | Supplement | 2021/10/26 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Hydromorphone Hydrochloride Extended-Release Tablets 3 records · Latest accepted 2022/07/11
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201047 | Generic | 2022/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2201046 | Generic | 2022/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2201045 | Generic | 2022/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Azithromycin Capsules 1 records · Latest accepted 2022/07/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250423 | Supplement | 2022/07/06 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Venlafaxine Hydrochloride Sustained-Release Capsules 3 records · Latest accepted 2022/06/21
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200911 | Generic | 2022/06/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200910 | Generic | 2022/06/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200909 | Generic | 2022/06/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Mycophenolate Sodium Enteric-coated Tablets 2 records · Latest accepted 2022/06/13
Generic · 2
芬太尼透皮贴剂(II) · No verified English name 1 records · Latest accepted 2022/06/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2200047 | Generic | 2022/06/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Vecuronium Bromide For Injection 1 records · Latest accepted 2022/06/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250306 | Supplement | 2022/06/01 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
RFUS-144注射液 · No verified English name 4 records · Latest accepted 2022/04/22
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2200249 | New drug | 2022/04/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2200248 | New drug | 2022/04/22 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2200247 | New drug | 2022/04/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2200246 | New drug | 2022/04/21 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Rivaroxaban Tablets 3 records · Latest accepted 2022/04/18
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200604 | Generic | 2022/04/18 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200603 | Generic | 2022/04/18 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2200602 | Generic | 2022/04/18 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Acetaminophen Injection 1 records · Latest accepted 2022/04/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200533 | Generic | 2022/04/07 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Yi Chang San Xia Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Azithromycin for Suspension 1 records · Latest accepted 2022/03/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200486 | Generic | 2022/03/25 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
异氟烷注射液 · No verified English name 1 records · Latest accepted 2022/02/28
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2200011 | New drug | 2022/02/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Oxycodone And Acetaminophen Tablets 1 records · Latest accepted 2022/01/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200109 | Generic | 2022/01/18 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Rocuronium Bromide Injection 1 records · Latest accepted 2021/12/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102346 | Generic | 2021/12/31 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
右美托咪定透皮贴剂(II) · No verified English name 1 records · Latest accepted 2021/12/28
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2101834 | New drug | 2021/12/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
盐酸右美托咪定鼻喷雾剂 · No verified English name 2 records · Latest accepted 2021/12/14
New drug · 2
Tofacitinib Citrate Extended Release tablets 1 records · Latest accepted 2021/12/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102177 | Generic | 2021/12/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Sugammadex Sodium Injection 1 records · Latest accepted 2021/12/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102134 | Generic | 2021/12/07 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Micafungin Sodium for Injection 1 records · Latest accepted 2021/11/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102060 | Generic | 2021/11/24 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
氨酚氢可酮缓释片 · No verified English name 2 records · Latest accepted 2021/09/29
Supplement · 1New drug · 1
烟酸缓释片 · No verified English name 3 records · Latest accepted 2021/09/07
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101698 | Generic | 2021/09/07 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2101697 | Generic | 2021/09/07 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2101696 | Generic | 2021/09/07 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
右美托咪定透皮贴剂 · No verified English name 1 records · Latest accepted 2021/05/24
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2101149 | New drug | 2021/05/24 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Butalbital, Acetaminophen, and Caffeine Capsules 1 records · Latest accepted 2021/04/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2101000 | Generic | 2021/04/23 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
氯化钾缓释片(I) · No verified English name 1 records · Latest accepted 2021/03/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100285 | Generic | 2021/03/16 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Changes in the last 90 days
21 events from 2026/08/16 to 2026/11/13. CDE data as of 2026/11/13 06:42; NMPA data as of 2026/11/12 18:32.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 15 applicationsNo longer listed under review: 4 applicationsSupplement delivery: 2 applications
- 2026/11/12Accepted
Buprenorphine Hydrochloride and Naloxone Hydrochloride Sublingual Tablets
CYHS2602803
Fact date: 2026/11/12 · Site observation date: 2026/11/13
View source ↗ - 2026/11/12Accepted
Buprenorphine Hydrochloride and Naloxone Hydrochloride Sublingual Tablets
CYHS2602802
Fact date: 2026/11/12 · Site observation date: 2026/11/13
View source ↗ - 2026/11/10Accepted
舒芬太尼透皮贴剂 · No verified English name
CXHB2600492
Fact date: 2026/11/10 · Site observation date: 2026/11/11
View source ↗ - 2026/11/10Accepted
舒芬太尼透皮贴剂 · No verified English name
CXHB2600491
Fact date: 2026/11/10 · Site observation date: 2026/11/11
View source ↗ - 2026/11/09Accepted
Brivaracetam Tablets
CYHS2602745
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ - 2026/11/09Accepted
Brivaracetam Tablets
CYHS2602744
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ - 2026/11/09Accepted
Brivaracetam Tablets
CYHS2602743
Fact date: 2026/11/09 · Site observation date: 2026/11/11
View source ↗ - 2026/11/05No longer listed under review
Midazolam Nasal Spray
CYHL2600092
Fact date: 2026/11/05 · Site observation date: 2026/11/05
Accepted: 2026/08/28
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/30No longer listed under review
Oseltamivir Phosphate For Oral Suspension
CYHS2500067
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2025/01/06
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/29No longer listed under review
Remimazolam Besylate For Injection
CYHB2601562
Fact date: 2026/10/29 · Site observation date: 2026/10/29
Accepted: 2026/08/17
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/29 (approval no.: —; approval date: 2026/10/27); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 9
NMPA · Table row 9 ↗ View source ↗ - 2026/10/29No longer listed under review
Remimazolam Besylate For Injection
CYHB2601561
Fact date: 2026/10/29 · Site observation date: 2026/10/29
Accepted: 2026/08/17
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/29 (approval no.: —; approval date: 2026/10/27); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 8
NMPA · Table row 8 ↗ View source ↗ - 2026/10/27Supplement delivery
Remimazolam Besylate For Injection
CYHB2601562
Fact date: 2026/10/27 · Publication date: 2026/10/29 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 9 ↗ - 2026/10/27Supplement delivery
Remimazolam Besylate For Injection
CYHB2601561
Fact date: 2026/10/27 · Publication date: 2026/10/29 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 8 ↗ - 2026/10/23Accepted
Granisetron Transdermal Patches
CYHS2602612
Fact date: 2026/10/23 · Site observation date: 2026/10/24
View source ↗ - 2026/09/08Accepted
HW231019片 · No verified English name
CXHB2600367
Fact date: 2026/09/08 · Site observation date: 2026/10/22
View source ↗ - 2026/08/28Accepted
Midazolam Nasal Spray
CYHL2600092
Fact date: 2026/08/28 · Site observation date: 2026/10/22
View source ↗ - 2026/08/27Accepted
Pregabalin Extended release Tablets
CYHS2602149
Fact date: 2026/08/27 · Site observation date: 2026/10/22
View source ↗ - 2026/08/27Accepted
Pregabalin Extended release Tablets
CYHS2602148
Fact date: 2026/08/27 · Site observation date: 2026/10/22
View source ↗ - 2026/08/27Accepted
Pregabalin Extended release Tablets
CYHS2602147
Fact date: 2026/08/27 · Site observation date: 2026/10/22
View source ↗ - 2026/08/17Accepted
Remimazolam Besylate For Injection
CYHB2601562
Fact date: 2026/08/17 · Site observation date: 2026/10/22
View source ↗ - 2026/08/17Accepted
Remimazolam Besylate For Injection
CYHB2601561
Fact date: 2026/08/17 · Site observation date: 2026/10/22
View source ↗
Under review
44 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/13 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Buprenorphine Hydrochloride and Naloxone Hydrochloride Sublingual Tablets | CYHS2602803 | Generic | 2026/11/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Buprenorphine Hydrochloride and Naloxone Hydrochloride Sublingual Tablets | CYHS2602802 | Generic | 2026/11/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| 舒芬太尼透皮贴剂 · No verified English name | CXHB2600492 | Supplement | 2026/11/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| 舒芬太尼透皮贴剂 · No verified English name | CXHB2600491 | Supplement | 2026/11/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Brivaracetam Tablets | CYHS2602745 | Generic | 2026/11/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Brivaracetam Tablets | CYHS2602744 | Generic | 2026/11/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Brivaracetam Tablets | CYHS2602743 | Generic | 2026/11/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Granisetron Transdermal Patches | CYHS2602612 | Generic | 2026/10/23 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| HW231019片 · No verified English name | CXHB2600367 | Supplement | 2026/09/08 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Pregabalin Extended release Tablets | CYHS2602149 | Generic | 2026/08/27 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Pregabalin Extended release Tablets | CYHS2602148 | Generic | 2026/08/27 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Pregabalin Extended release Tablets | CYHS2602147 | Generic | 2026/08/27 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Pregabalin Extended release Tablets | CYHS2602018 | Generic | 2026/08/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Pregabalin Extended release Tablets | CYHS2602017 | Generic | 2026/08/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Pregabalin Extended release Tablets | CYHS2602016 | Generic | 2026/08/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Clobazam Tablets | CYHB2601549 | Supplement | 2026/08/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Clobazam Tablets | CYHB2601548 | Supplement | 2026/08/14 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Mirogabalin Besilate Tablets | CYHS2601981 | Generic | 2026/08/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Landiolol Hydrochloride for Injection | CYHS2601236 | Generic | 2026/06/01 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Dexmethylphenidate Hydrochloride Exended-release Capsules | CYHS2600792 | Generic | 2026/04/08 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Dexmethylphenidate Hydrochloride Exended-release Capsules | CYHS2600791 | Generic | 2026/04/08 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| 氨酚羟考酮缓释片 · No verified English name | CXHS2600041 | New drug | 2026/03/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| 马立巴韦片 · No verified English name | CYHS2600631 | Generic | 2026/03/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Carbamazepine Tablets | CYHB2600291 | Supplement | 2026/02/10 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Nalbuphine Hydrochloride Injection | CXHS2600013 | New drug | 2026/01/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Nalbuphine Hydrochloride Injection | CXHS2600012 | New drug | 2026/01/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Nalbuphine Hydrochloride Injection | CXHS2600011 | New drug | 2026/01/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Palonosetron Hydrochloride Soft Capsules | CYHS2600084 | Generic | 2026/01/07 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Ren Fu Pu Ke Pharma (Wuhan) Co., Ltd. romanized | CDE ↗ |
| Loxoprofen Sodium Patches | CYHS2504298 | Generic | 2025/12/17 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Hunan Pai Ge Lan Pharma Co., Ltd. romanized | CDE ↗ |
| Loxoprofen Sodium Patches | CYHS2504297 | Generic | 2025/12/17 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Hunan Pai Ge Lan Pharma Co., Ltd. romanized | CDE ↗ |
| Lisdexamfetamine Dimesylate capsules | CYHS2504006 | Generic | 2025/11/19 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Lisdexamfetamine Dimesylate capsules | CYHS2504004 | Generic | 2025/11/19 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Lisdexamfetamine Dimesylate capsules | CYHS2504003 | Generic | 2025/11/19 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Lisdexamfetamine Dimesylate capsules | CYHS2504001 | Generic | 2025/11/19 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Gadoxetic Acid Disodium Injection | CYHS2503940 | Generic | 2025/11/12 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Pemafibrate Tablets | CYHS2503652 | Generic | 2025/10/13 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Letermovir Tablets | CYHS2503589 | Generic | 2025/09/30 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Gadobutrol Injection | CYHS2503327 | Generic | 2025/09/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Gadobutrol Injection | CYHS2503326 | Generic | 2025/09/09 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Valganciclovir Hydrochloride Tablets | CYHS2502702 | Generic | 2025/07/28 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | CDE ↗ |
| Guanfacine Hydrochloride Extended Release Tablets | CYHS2502473 | Generic | 2025/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Guanfacine Hydrochloride Extended Release Tablets | CYHS2502472 | Generic | 2025/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Guanfacine Hydrochloride Extended Release Tablets | CYHS2502471 | Generic | 2025/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Guanfacine Hydrochloride Extended Release Tablets | CYHS2502470 | Generic | 2025/07/11 | Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
Catalogue holder records
113 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/13 06:39. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 维生素B12注射液 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20269189 | 2026/08/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 维生素B6注射液 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20269181 | 2026/07/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Brexpiprazole Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20265402 | 2026/07/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carbamazepine Sustained-Release Tablets（II） | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20265217 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carbamazepine Sustained-Release Tablets（II） | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20265218 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carbamazepine Sustained-Release Tablets（II） | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20265216 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 对乙酰氨基酚甘露醇注射液 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Guangzhou Lv Shi Zi Pharmaceutical Co., Ltd. romanized | 国药准字H20269108 | 2026/05/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Norepinephrine Bitartrate Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20255191 | 2025/08/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amikacin Sulfate injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42021992 | 2025/07/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Oxycodone Hydrochloride Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20254596 | 2025/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oxycodone Hydrochloride Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20254595 | 2025/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 氢可酮布洛芬片 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20254118 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 氢可酮布洛芬片 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20254119 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Valacyclovir Hydrochloride Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20258047 | 2025/03/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tapentadol Hydrochloride Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20253386 | 2025/02/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dimethyl Fumarate Delayed-release Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20253259 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 琥珀酸地文拉法辛缓释片 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20253250 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 琥珀酸地文拉法辛缓释片 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20253251 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 琥珀酸地文拉法辛缓释片 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20253249 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Midazolam Maleate Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20253111 | 2025/01/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Celecoxib Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20249827 | 2024/12/25 | Not stated by source | CDE ↗ |
| 依托咪酯中/长链脂肪乳注射液 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20249700 | 2024/12/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ursodeoxycholic Acid Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20249666 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tolterodine Tartrate Extended Release Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20249396 | 2024/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tolterodine Tartrate Extended Release Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20249395 | 2024/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Febuxostat Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20247281 | 2024/11/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方醋酸钠林格注射液 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang San Xia Pharmaceutical Co., Ltd. romanized | 国药准字H20249110 | 2024/10/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Hydromorphone Hydrochloride Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20217021 | 2024/09/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lincomycin Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42022003 | 2024/09/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 烟酸缓释片 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20244859 | 2024/09/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fosaprepitant Dimeglumine for Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20244661 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Piracetam Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42022130 | 2024/08/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Piracetam Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20247185 | 2024/08/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Esketamine Hydrochloride Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20244192 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | 国药准字H20244310 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20244013 | 2024/06/11 | Not stated by source | CDE ↗ |
| Vonoprazan Fumarate Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20244014 | 2024/06/11 | Not stated by source | CDE ↗ |
| Oxycodone Hydrochloride Prolonged-release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20247091 | 2024/04/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Enzalutamide Soft Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20243243 | 2024/02/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mycophenolate Sodium Enteric-coated Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20243022 | 2024/01/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mycophenolate Sodium Enteric-coated Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20243021 | 2024/01/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paracetamol and Tramadol Hydrochloride Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20100184 | 2024/01/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Hydromorphone Hydrochloride Extended-Release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20234712 | 2023/12/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Hydromorphone Hydrochloride Extended-Release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20234713 | 2023/12/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Hydromorphone Hydrochloride Extended-Release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20234714 | 2023/12/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oxycodone And Acetaminophen Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20234679 | 2023/12/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 对乙酰氨基酚甘露醇注射液 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang San Xia Pharmaceutical Co., Ltd. romanized | 国药准字H20234619 | 2023/12/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sufentanil Citrate Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20237165 | 2023/11/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rocuronium Bromide Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20234518 | 2023/11/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20234361 | 2023/10/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nalbuphine Hydrochloride Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20237124 | 2023/10/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azithromycin for Suspension | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20234182 | 2023/09/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azithromycin Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20093956 | 2023/07/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metoprolol Succinate Sustained-release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20233952 | 2023/07/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vecuronium Bromide For Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20133079 | 2023/07/03 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Micafungin Sodium for Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20233637 | 2023/05/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tofacitinib Citrate Extended Release tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20233549 | 2023/05/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sugammadex Sodium Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223895 | 2022/11/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Propofol Medium And Long Chain Fat Emulsion Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223721 | 2022/10/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oxycodone Hydrochloride Prolonged-release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223693 | 2022/09/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Clobazam Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223677 | 2022/09/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Clobazam Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223678 | 2022/09/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tenofovir alafenamide Fumarate Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223637 | 2022/08/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nalbuphine Hydrochloride Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20227102 | 2022/08/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metoprolol Succinate Sustained-release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223517 | 2022/07/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metoprolol Succinate Sustained-release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223518 | 2022/07/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Potassium Chloride Extended Release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223295 | 2022/05/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Meperidine Hydrochloride Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42022074 | 2022/03/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Memantine Hydrochloride Sustained-release Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223042 | 2022/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Memantine Hydrochloride Sustained-release Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223041 | 2022/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Memantine Hydrochloride Sustained-release Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223043 | 2022/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Memantine Hydrochloride Sustained-release Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223040 | 2022/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefalexin Capsules | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42022066 | 2022/01/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Entecavir Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20223005 | 2022/01/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Naproxen Sodium Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20213883 | 2021/11/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metoprolol Tartrate Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20193341 | 2021/08/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Omeprazole Sodium for Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20054382 | 2021/08/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 盐酸安非他酮缓释片(II) · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20213640 | 2021/08/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 盐酸安非他酮缓释片(II) · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20213641 | 2021/08/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Hydromorphone Hydrochloride Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20120095 | 2021/07/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Hydromorphone Hydrochloride Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20120094 | 2021/07/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Hydromorphone Hydrochloride Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20120100 | 2021/07/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sufentanil Citrate Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20205068 | 2021/07/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Carbamazepine Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42022117 | 2021/06/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Potassium Chloride Extended Release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20213363 | 2021/05/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Potassium Chloride Extended Release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20213364 | 2021/05/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Compound Sulfamethoxazole Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42022114 | 2021/05/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Midazolam Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20067041 | 2021/03/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nalbuphine Hydrochloride Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20130127 | 2021/03/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Midazolam Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20067040 | 2021/03/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Flumazenil Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20113191 | 2021/03/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dexmedetomidine Hydrochloride Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20183390 | 2021/01/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Fentanyl Citrate Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20003688 | 2020/12/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Fentanyl Citrate Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42022076 | 2020/12/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sufentanil Citrate Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20054172 | 2020/12/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sufentanil Citrate Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20054256 | 2020/12/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Remifentanil Hydrochloride for Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20030200 | 2020/12/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Remifentanil Hydrochloride for Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20030199 | 2020/12/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Remifentanil Hydrochloride for Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20030197 | 2020/12/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ropivacaine hydrochloride injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20103552 | 2020/12/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ropivacaine hydrochloride injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20103636 | 2020/12/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ropivacaine hydrochloride injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20103553 | 2020/12/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sufentanil Citrate Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20054171 | 2020/12/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levobupivacaine Hydrochloride Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20193347 | 2020/12/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levobupivacaine Hydrochloride Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20193348 | 2020/12/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ibuprofen Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42021961 | 2020/09/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metformin Hydrochloride Extended-release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20203371 | 2020/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metformin Hydrochloride Extended-release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20203312 | 2020/07/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ethambutol Hydrochloride Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H42022126 | 2020/01/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Oxycodone Hydrochloride Prolonged-release Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20269023 | 2026/01/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Brexpiprazole Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20265400 | 2026/07/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Brexpiprazole Tablets | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20265401 | 2026/07/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Flurbiprofen Axetil Injection | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20255400 | 2025/09/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
43 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/13 06:41.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 盐酸右哌甲酯 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20250001457 | I | 2026/01/08 | CDE ↗ |
| 二甲磺酸利右苯丙胺 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20250000958 | I | 2025/09/17 | CDE ↗ |
| 布他比妥 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20240001273 | I | 2024/11/19 | CDE ↗ |
| 丁丙诺啡 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20230001183 | A | 2025/04/28 | CDE ↗ |
| 盐酸他喷他多 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20230000802 | A | 2025/02/27 | CDE ↗ |
| 氯巴占 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20220000098 | A | 2022/09/22 | CDE ↗ |
| 格拉司琼 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20220000059 | A | 2024/08/23 | CDE ↗ |
| 福沙匹坦双葡甲胺 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20210000706 | A | 2025/11/05 | CDE ↗ |
| 磷丙泊酚二钠 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20200001533 | A | 2025/11/22 | CDE ↗ |
| 氟比洛芬酯 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20210000155 | A | 2024/12/27 | CDE ↗ |
| 氯巴占 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20200001163 | I | 2020/11/17 | CDE ↗ |
| 苯磺酸瑞马唑仑 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190021626 | A | 2025/08/14 | CDE ↗ |
| 依托咪酯 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190021553 | A | 2026/02/07 | CDE ↗ |
| 二甲磺酸赖右苯丙胺 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190021510 | I | 2020/01/15 | CDE ↗ |
| 盐酸艾司氯胺酮 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190021512 | A | 2026/02/07 | CDE ↗ |
| 盐酸纳布啡 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190009863 | A | 2023/06/27 | CDE ↗ |
| 咪达唑仑 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190008835 | A | 2025/11/22 | CDE ↗ |
| 盐酸克林霉素 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190008081 | A | 2025/12/19 | CDE ↗ |
| 盐酸纳洛酮 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190007344 | A | 2023/07/26 | CDE ↗ |
| 卡络磺钠 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190007032 | A | 2023/03/24 | CDE ↗ |
| 盐酸氢吗啡酮 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190006880 | A | 2023/03/24 | CDE ↗ |
| 山梨醇 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190005302 | A | 2025/12/19 | CDE ↗ |
| 维生素C · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190005300 | A | 2025/12/19 | CDE ↗ |
| 磺胺嘧啶 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190005297 | A | 2025/12/19 | CDE ↗ |
| 诺氟沙星 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190005293 | A | 2025/12/19 | CDE ↗ |
| 盐酸可乐定 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190005291 | A | 2025/12/19 | CDE ↗ |
| 非诺贝特 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190005290 | A | 2025/12/19 | CDE ↗ |
| 甘氨酸 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190005273 | A | 2025/12/19 | CDE ↗ |
| 安那度尔 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190005272 | A | 2025/12/19 | CDE ↗ |
| 盐酸洛美沙星 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190005271 | A | 2025/12/19 | CDE ↗ |
| 磷酸可待因 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190003692 | A | 2025/12/19 | CDE ↗ |
| 枸橼酸舒芬太尼 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190003673 | A | 2025/05/29 | CDE ↗ |
| 盐酸瑞芬太尼 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190003663 | A | 2025/05/29 | CDE ↗ |
| 山梨醇(供口服用) · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190003662 | A | — | CDE ↗ |
| 盐酸哌替啶 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190003654 | A | 2025/12/19 | CDE ↗ |
| 枸橼酸芬太尼 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190003653 | A | 2025/05/29 | CDE ↗ |
| 福尔可定 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190003652 | A | 2025/05/29 | CDE ↗ |
| 奥扎格雷 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20190003651 | A | 2025/05/29 | CDE ↗ |
| 盐酸纳布啡 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20180001356 | A | 2025/11/22 | CDE ↗ |
| 盐酸阿芬太尼 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20170001895 | A | 2026/11/11 | CDE ↗ |
| 盐酸右美托咪定 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20170001405 | A | 2024/01/17 | CDE ↗ |
| 马来酸咪达唑仑 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20170001064 | A | 2026/11/05 | CDE ↗ |
| 芬太尼 · No verified English name | Yi Chang Ren Fu Pharma Co., Ltd. romanized | Y20170000746 | A | 2025/05/14 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
6 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/13 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Levodopa and Benserazide Hydrochloride Tablets | CYHS2400184 | Generic | 2024/01/12 | Wuhan Ren Fu Pharma Co., Ltd. romanized; Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Levodopa and Benserazide Hydrochloride Tablets | CYHS2302919 | Generic | 2023/10/27 | Wuhan Ren Fu Pharma Co., Ltd. romanized; Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Esomeprazole Magnesium Enteric-Coated Capsules | CYHS2301835 | Generic | 2023/07/07 | Guangzhou Xin Ji Pharma Technology Co., Ltd. romanized; Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| Esomeprazole Magnesium Enteric-Coated Capsules | CYHS2301834 | Generic | 2023/07/07 | Guangzhou Xin Ji Pharma Technology Co., Ltd. romanized; Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| LL-50注射液 · No verified English name | CXHL2300531 | New drug | 2023/05/17 | Sichuan University Hua Xi Hospital romanized; Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
| 注射用RF16001 · No verified English name | CXHL2101621 | New drug | 2021/10/29 | Beijing Hui Li Technology Co., Ltd. romanized; Yi Chang Ren Fu Pharma Co., Ltd. romanized | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
- Full API register
- Last successful update: 2026/11/13 06:41
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.